Related Experiment Video
Updated: May 30, 2026
08:57
En Face Endocardial Cushion Preparation for Planar Morphogenesis Analysis in Mouse Embryos
Published on: July 27, 2022
Atrial natriuretic factor in the developing heart: a signpost for cardiac morphogenesis
1Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, CA 94158, USA. bbruneau@gladstone.ucsf.edu
Canadian Journal of Physiology and Pharmacology
|August 3, 2011
Summary
Congenital heart defects (CHDs) arise from errors in heart development. Atrial Natriuretic Factor (ANF) expression patterns reveal early molecular defects, aiding CHD research.
Area of Science:
- Cardiovascular Science
- Developmental Biology
- Genetics
Background:
- Congenital heart defects (CHDs) are common birth abnormalities.
- Understanding the molecular basis of heart development is crucial for CHD research.
- Atrial Natriuretic Factor (ANF) is a sensitive marker in cardiac development.
Purpose of the Study:
- To review the dynamic expression of ANF during heart development.
- To highlight ANF's utility in identifying early molecular defects in CHDs.
Main Methods:
- Literature review of studies on ANF expression in embryonic hearts.
- Analysis of ANF's role as a marker for cardiac patterning and defects.
Main Results:
- ANF expression is dynamically regulated during heart embryogenesis.
- ANF expression patterns correlate with specific developing heart regions.
- ANF serves as an indicator of disturbances in cardiac patterning.
Conclusions:
- Dynamic ANF expression is key to understanding normal heart development.
- ANF is a valuable tool for investigating the molecular etiology of CHDs.
- Further research into ANF's role can advance CHD diagnostics and treatments.
More Related Videos
Related Concept Videos
01:27Development of the Heart
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:51Determination
During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...